"Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "

Epstein-Barr virus (EBV) is a ubiquitous human -herpesvirus that infects about 95% of the adult population. The majority of primary infections occurs in early childhood and is generally subclinical; it can cause infectious mononucleosis (IM), which is usually a self-limiting lymphoproliferative dis...

Full description

Bibliographic Details
Main Author: Toshio Miyawaki
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2004-06-01
Series:Iranian Journal of Allergy, Asthma and Immunology
Subjects:
Online Access:https://ijaai.tums.ac.ir/index.php/ijaai/article/view/68
_version_ 1811276745427386368
author Toshio Miyawaki
author_facet Toshio Miyawaki
author_sort Toshio Miyawaki
collection DOAJ
description Epstein-Barr virus (EBV) is a ubiquitous human -herpesvirus that infects about 95% of the adult population. The majority of primary infections occurs in early childhood and is generally subclinical; it can cause infectious mononucleosis (IM), which is usually a self-limiting lymphoproliferative disorder. However, infection of EBV occasionally results in severe, often lethal diseases, which include fatal IM, hemophagocytic syndrome, polyclonal lymphoproliferative disorders, and malignant lymphoma. These severe EBV-related illnesses occur secondary to some primary immunodeficiency diseases showing inefficient immune reaction to EBV. One example is X-linked lymphoproliferative disease (XLP), which is caused by mutations in the SLAM-associated protein (SAP) gene. The major clinical manifestations of XLP are fulminant IM, malignant lymphoma and dysgammaglobulinemia. Aplastic anemia, virus-associated hemophagocytic syndrome, and vasculitis have also been reported in XLP. We have developed a flow cytometric method using the anti-SAP monoclonal antibody to search for XLP. This clinically useful assay has successfully been used to identify XLP patients in Japan. In this review, clinical and mutational characteristics of XLP in Japan are mainly described. In addition, it is shown that the similar situations to XLP can occur in other primary immunodeficiencies involving T-cell killing function, such as autoimmune lymphoproliferative syndrome caused by Fas gene mutations or familial hemophagocytic lymphohistiocytosis caused by perforin gene mutations. Finally, the EBV-related terrible disease condition, namely chronic active EBV infection, which is common in Asian areas but its genetic background remains to be elucidated, will be toughed on.
first_indexed 2024-04-13T00:03:17Z
format Article
id doaj.art-2b5bde808bc34f238b5996c84ae916d5
institution Directory Open Access Journal
issn 1735-1502
1735-5249
language English
last_indexed 2024-04-13T00:03:17Z
publishDate 2004-06-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Allergy, Asthma and Immunology
spelling doaj.art-2b5bde808bc34f238b5996c84ae916d52022-12-22T03:11:17ZengTehran University of Medical SciencesIranian Journal of Allergy, Asthma and Immunology1735-15021735-52492004-06-013268"Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses " Toshio Miyawaki0 Epstein-Barr virus (EBV) is a ubiquitous human -herpesvirus that infects about 95% of the adult population. The majority of primary infections occurs in early childhood and is generally subclinical; it can cause infectious mononucleosis (IM), which is usually a self-limiting lymphoproliferative disorder. However, infection of EBV occasionally results in severe, often lethal diseases, which include fatal IM, hemophagocytic syndrome, polyclonal lymphoproliferative disorders, and malignant lymphoma. These severe EBV-related illnesses occur secondary to some primary immunodeficiency diseases showing inefficient immune reaction to EBV. One example is X-linked lymphoproliferative disease (XLP), which is caused by mutations in the SLAM-associated protein (SAP) gene. The major clinical manifestations of XLP are fulminant IM, malignant lymphoma and dysgammaglobulinemia. Aplastic anemia, virus-associated hemophagocytic syndrome, and vasculitis have also been reported in XLP. We have developed a flow cytometric method using the anti-SAP monoclonal antibody to search for XLP. This clinically useful assay has successfully been used to identify XLP patients in Japan. In this review, clinical and mutational characteristics of XLP in Japan are mainly described. In addition, it is shown that the similar situations to XLP can occur in other primary immunodeficiencies involving T-cell killing function, such as autoimmune lymphoproliferative syndrome caused by Fas gene mutations or familial hemophagocytic lymphohistiocytosis caused by perforin gene mutations. Finally, the EBV-related terrible disease condition, namely chronic active EBV infection, which is common in Asian areas but its genetic background remains to be elucidated, will be toughed on.https://ijaai.tums.ac.ir/index.php/ijaai/article/view/68illness
spellingShingle Toshio Miyawaki
"Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
Iranian Journal of Allergy, Asthma and Immunology
illness
title "Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
title_full "Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
title_fullStr "Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
title_full_unstemmed "Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
title_short "Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses "
title_sort primary immunodeficiencies inducing ebv associated severe illnesses
topic illness
url https://ijaai.tums.ac.ir/index.php/ijaai/article/view/68
work_keys_str_mv AT toshiomiyawaki primaryimmunodeficienciesinducingebvassociatedsevereillnesses